0001225208-16-037271.txt : 20160801
0001225208-16-037271.hdr.sgml : 20160801
20160801203756
ACCESSION NUMBER: 0001225208-16-037271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160728
FILED AS OF DATE: 20160801
DATE AS OF CHANGE: 20160801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verguet Patrick B
CENTRAL INDEX KEY: 0001308771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 161798710
MAIL ADDRESS:
STREET 1: CHEMIN CHANTEBISE 19
CITY: COMMUNGNY
STATE: V8
ZIP: 1291
4
1
doc4.xml
X0306
4
2016-07-28
0001099800
Edwards Lifesciences Corp
EW
0001308771
Verguet Patrick B
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, Europe
Common Stock
2016-07-28
4
M
0
5000.0000
25.4800
A
133952.1610
D
Common Stock
2016-07-28
4
S
0
5000.0000
115.0000
D
128952.1610
D
Common Stock
2016-07-29
4
M
0
5000.0000
25.4800
A
133998.5766
D
Common Stock
2016-07-29
4
S
0
5000.0000
114.7343
D
128998.5766
D
Employee Stock Option (Right to Acquire)
25.4800
2016-07-28
4
M
0
5000.0000
0.0000
D
2011-05-13
2017-05-12
Common Stock
5000.0000
83000.0000
D
Employee Stock Option (Right to Acquire)
25.4800
2016-07-29
4
M
0
5000.0000
0.0000
D
2011-05-13
2017-05-12
Common Stock
5000.0000
78000.0000
D
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $114.7301 to $114.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Ifigenia Protopappas, Attorney-in-fact
2016-08-01